Thesis
Investigation of P2Y? and P2Y?? receptor heterodimerisation
- Creator
- Rights statement
- Awarding institution
- University of Strathclyde
- Date of award
- 2014
- Thesis identifier
- T13789
- Qualification Level
- Qualification Name
- Department, School or Faculty
- Abstract
- Heterodimerisation of G-Protein Coupled Receptors (GPCR) is an emerging research niche with implications for understanding signalling, pathophysiology and development of new drug targets. This research investigates P2Y? and P2Y?? receptor heterodimerisation. Individually, these class-A GPCR are stimulated by adenine and/or uridine nucleotides in a range of tissue. They are highly expressed in platelets and dorsal root ganglion (DRG) sensory neurons, giving rise to a host of physiological functions such as platelet degranulation and nociception. A previous study in the laboratory suggested that when recombinant hP2Y?? receptors are expressed in tsA201 cells they interact with the native P2Y? receptors to form functional heterodimers with novel pharmacological and signalling properties (Shakya-Shrestha, et al., 2010). A disadvantage of this study was that it was low throughput and only a single agonist concentration was used in patch-clamp electrophysiology recordings from single cells. The present study used Ca²? imaging in a cell population to produce high throughput, multiple agonist concentration analysis. Part of the challenge to this research was to identify how P2Y? receptor (G?q/11 coupled) and P2Y?? receptor (G?i/o coupled) signalling was affected by co-expression in tsA201 bioassays. By using the selective P2Y? receptor antagonist, MRS2179, our data demonstrates that the P2Y? receptor is the dominant endogenously-expressed purinergic receptor in tsA201 cells. We then showed that the selective P2Y?? receptor antagonist, AR-C69931MX, significantly inhibited Ca²? signalling in hP2Y??-transfected, but not wild-type tsA201. Lastly, we transfected both hP2Y? and hP2Y?? receptors into tsA201 cells (overexpressing hP2Y?) and identified a reversal in the inhibitory actions of AR-C69931MX, compared to the hP2Y?? receptor expressed bioassay. The change in pharmacology observed is consistent with P2Y? and P2Y?? receptor heterodimerisation.
- Resource Type
- DOI
- Date Created
- 2014
- Former identifier
- 1036541
Relations
Items
| Thumbnail | Title | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|
|
|
File | 2021-07-02 | University of Strathclyde |